Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christian Drosten and Simon Schroeder.
Christian Drosten
Connection Strength
1.389
Simon Schroeder
  1. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021 May; 2(5):e210-e218.
    View in: PubMed
    Score: 0.933
  2. Transgene expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing Red-mediated recombination cloning. J Gen Virol. 2017 Oct; 98(10):2461-2469.
    View in: PubMed
    Score: 0.184
  3. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021 06 21; 12(1):3818.
    View in: PubMed
    Score: 0.060
  4. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 05 21; 64(6).
    View in: PubMed
    Score: 0.055
  5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 04 16; 181(2):271-280.e8.
    View in: PubMed
    Score: 0.054
  6. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2020; 9(1):155-168.
    View in: PubMed
    Score: 0.054
  7. Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017. Emerg Microbes Infect. 2018 Nov 28; 7(1):195.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.